A Bioequivalence Study of Different Formulations of SEP-190 and Food Effect Study in Japanese Healthy Adult Males.

Trial Profile

A Bioequivalence Study of Different Formulations of SEP-190 and Food Effect Study in Japanese Healthy Adult Males.

Completed
Phase of Trial: Phase I

Latest Information Update: 11 Feb 2013

At a glance

  • Drugs Eszopiclone (Primary)
  • Indications Depressive disorders; Generalised anxiety disorder; Insomnia
  • Focus Pharmacokinetics
  • Sponsors Eisai Inc
  • Most Recent Events

    • 11 Feb 2013 Primary endpoints amended as reported by ClinicalTrials.gov.
    • 08 Jun 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 02 Feb 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top